Print Published 23rd Mar 2018, 12:25

Cello reports £4.2m post-tax profit as abnormalities decline

Cello Group, the AIM-listed marketing group that now focusses almost exclusively on healthcare, has decided to change its name to Cello Health after reporting a return to profit in 2017.

Cello has a long history of recording substantial abnormal charges in its accounts (see chart) – so much so that an absence of such items would itself be abnormal.  In 2016 the group reported a post-tax loss of £2.8 million after bearing abnormal items of £11.2 million.